C6: synthesis by the liver in vivo by unknown
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C6 shows a common genetic polymorphism in humans (Hobart et al. 1). There 
are three common phenotypes: C6A with a frequency of about 37%,  C6B:  14%, 
and C6AB: 45%. Where the phenotype of  the donor of  an organ transplant differs 
from that of the recipient it is possible to investigate whether the transplanted 
organ is the site of  synthesis of C6. This approach has previously been applied to 
C3 by Alper et al. (2), who were able to show that the liver is the principal site of 
C3 synthesis in man. 
Methods, Materials, and Results 
C6 allotyping was carried out by the method of Hobart et al.  (1), by using a 
thin slab polyacrylamide gel electrofocusing, followed by a  functional overlay 
technique. 
The patient reported here was a  51-yr-old male with biliary cirrhosis.  The 
liver donor was a  52-yr-old male who died after a  subarachnoid hemorrhage. 
Serum samples were obtained from the donor; and before, 10 days after, and 17 
wk  after  operation  from the  recipient.  10  pints  of blood  were  given to  the 
recipient at the time of  operation and 2 further pints during the subsequent 24 h. 
The postoperative course was uneventful and the patient was in good health 17 
wk after the operation. 
The phenotypes of the patient and donor are shown in Table I. 
Discussion 
The  results  show  an  unequivocal  and  total  conversion  of the  recipient's 
phenotype to that of the liver donor at 10 days and at 17 wk after transplanta- 
tion. Since the type of donor was B, the least common of the three common C6 
phenotypes the result is especially clear. Were there any residual C6 from blood 
transfusion or from the patient's own synthesis before transplantation, it would 
be expected to contain a significant level of A phenotype since this was the type 
of the  recipient  and  is  present  in  83%  of the  normal  population  either  as 
homozygous or heterozygous phenotype. 
The finding that the liver is the principal site of C6 synthesis in vivo accords 
well with the report that rabbit liver slices synthesizes C6 in vitro (Rother et al. 
3). 
The result reported here provides information on the organ rather than the 
cell type involved in C6  synthesis. The total nature of the conversion would 
however, be easier to understand if it were the hepatocytes which make C6. 
In the case of C3 where total conversion of phenotype was also found (Alper et 
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TABLE  I 
C6 Phenotypes 
Recipient 
Donor 
Before operation  10 days postoperatively  17 wk postoperatively 
B  A  B  B 
(No C6 of A pattern  (No C6 of A pattern 
visible)  visible) 
al., 2), it is nevertheless known that C3 can be made by monocytoid cell lines in 
vitro (Einstein et al.  [4]) and by the rheumatoid synovium (Ruddy and Colten 
5).  It  therefore seems  inescapable  that  C3  can  be  made  by  cells  other than 
hepatocytes and a  similar result cannot be excluded for C6. 
Summary 
The  allotype  of the  sixth  component  of complement  was  determined  in  a 
patient before and after liver transplantation.  The C6 phenotype changed from 
A  before  transplantation  to  B  (the  donor  phenotype)  within  10  days  of the 
transplant and remained wholly of the donor phenotype at 17 wk. This demon- 
strates that the liver is the exclusive or predominant site of C6 synthesis in vivo 
in man. 
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